Consolidated Balance Sheets - USD ($) $ in Thousands	May 31, 2024	May 31, 2023
Current Assets
Cash and cash equivalents	$ 76,056	$ 44,620
Accounts receivable, net of allowances of $2,141 and $2,150 respectively	43,610	52,826
Inventories	60,616	55,325
Prepaid expenses and other	12,971	4,617
Current assets held for sale	0	6,154
Total current assets	193,253	163,542
Property, plant and equipment, net	35,666	44,384
Intangible assets, net	77,383	111,144
Goodwill	0	159,238
Other assets	11,369	10,676
Non-current assets held for sale	0	43,653
Total Assets	317,671	532,637
Current Liabilities
Accounts payable	37,751	40,445
Accrued liabilities	41,098	26,617
Current portion of contingent consideration	4,728	14,761
Other current liabilities	7,578	2,002
Total current liabilities	91,155	83,825
Long-term debt	0	49,818
Deferred income taxes	4,852	12,813
Contingent consideration, net of current portion	0	4,535
Other long-term liabilities	16,078	3,350
Total Liabilities	112,085	154,341
Commitments and Contingencies (Note 17)
Stockholders’ Equity
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 40,801,597 and 39,981,422 shares issued and 40,431,597 and 39,611,422 shares outstanding at May 31, 2024 and 2023, respectively	385	382
Additional paid-in capital	610,484	599,206
Accumulated deficit	(395,204)	(210,855)
Treasury stock, 370,000 shares, at cost at May 31, 2024 and 2023, respectively	(5,714)	(5,714)
Accumulated other comprehensive loss	(4,365)	(4,723)
Total Stockholders' Equity	205,586	378,296
Total Liabilities and Stockholders' Equity	$ 317,671	$ 532,637